Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
Calgary, Alberta--(Newsfile Corp. - June 12, 2023) - Resverlogix Corp. (TSX: RVX) ("Resverlogix") today announced a peer-reviewed article, entitled, "Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment," by Dr. Dean Gilham and colleagues, was published in Biomedicines, a prestigious scientific journal. The article explores the favorable impact of apabetalone treatment on kidney cells and its implications for the...
2023-06-12 7:15 AM EDT
Resverlogix Announces One-Year Extension of Debenture
Calgary, Alberta--(Newsfile Corp. - March 20, 2023) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") announced today that it has closed a one-year extension of Company's US$6.0 million secured convertible debenture with Shenzhen Hepalink Pharmaceutical Group Co., Ltd. ("Hepalink"), and payment of accrued interest thereon, extending the maturity date to May 13, 2024. In connection with the extension, the interest rate was amended from 10% to 12% per annum, commencing on May 14,...
2023-03-20 7:15 AM EDT
Resverlogix Announces New Research Highlighting Apabetalone's Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19
Calgary, Alberta--(Newsfile Corp. - March 2, 2023) - Resverlogix Corp. (TSX: RVX) ("Resverlogix") today announced the publication of two articles in peer-reviewed scientific journals. The first, entitled "Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation" by Fu et al., was published in International Immunopharmacology, and positions apabetalone as a variant-independent therapeutic for...
2023-03-02 7:15 AM EST
IIROC Trade Resumption - Resverlogix Corp.
Toronto, Ontario--(Newsfile Corp. - October 13, 2017) - Trading resumes in: Company: Resverlogix Corp.
2017-10-13 9:33 AM EDT
IIROC Trade Halt - Resverlogix Corp.
Toronto, Ontario--(Newsfile Corp. - October 13, 2017) - The following issues have been halted by IIROC: Company:
2017-10-13 9:22 AM EDT
IIROC Trade Resumption - Resverlogix Corp.
Toronto, Ontario--(Newsfile Corp. - July 25, 2017) - Trading resumes in: Company: Resverlogix Corp.
2017-07-25 9:07 AM EDT
CORRECTION FROM SOURCE: IIROC Trade Halt - Resverlogix Corp.
Toronto, Ontario--(Newsfile Corp. - July 25, 2017) - The following issues have been halted by IIROC: Company:
2017-07-25 8:03 AM EDT
IIROC Trade Halt - Resverlogix Corp.
Toronto, Ontario--(Newsfile Corp. - July 25, 2017) - The following issues have been halted by IIROC: Company:
2017-07-25 8:02 AM EDT
IIROC Trade Resumption - Resverlogix Corp.
Toronto, Ontario--(Newsfile Corp. - June 20, 2017) - Trading resumes in: Company: Resverlogix Corp.
2017-06-20 9:51 AM EDT
IIROC Trade Halt - Resverlogix Corp.
Toronto, Ontario--(Newsfile Corp. - June 20, 2017) - The following issues have been halted by IIROC: Company:
2017-06-20 8:11 AM EDT